- Human pathology

Home > A. Molecular pathology > MYD88


Tuesday 10 April 2012


- MYD88-p.L265P

  • Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma. 24531446
  • MYD88 L265P somatic mutation in Waldenström’s macroglobulinemia. 22931316, 23532735, 23723443
    • L265P mutation of the MYD88 gene is frequent in Waldenström’s macroglobulinemia and its absence in myeloma. 24224040
    • MYD88 L265P mutations are correlated with 6q deletion in korean patients with Waldenström macroglobulinemia. 24895570

See also

- Toll-like receptor pathways